Focalyx Technologies, LLC. recalls Focalyx Fusion
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Software device that is an accessory for image-guided interventional and diagnostic procedures involving prostate has accessories that may not function properly with Windows 10, which may cause patient harm during biopsy or cause treatment/therapy delays, so firm is recommending stop use until device is verified/validated with Windows 11.
- Products
-
- Focalyx Fusion
- Company
- Focalyx Technologies, LLC.
- Where it was sold
-
Worldwide - US Nationwide distribution in the states of NY, MA, FL and the countries of ES, VE, DO.
States: Florida, Massachusetts, New York
- Barcodes
00860003552001- Units affected
- 18
- About this recall
- Focalyx Fusion